Tyrosine Kinase Inhibitors in EGFR-Mutated Large-Cell Neuroendocrine Carcinoma of the Lung A Case Report

Publisher： Karger

E-ISSN： 1662-6575|7|2|478-483

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.7, Iss.2, 2014-07, pp. : 478-483

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Challenges in the Management of EGFR-Mutated Non-Small Cell Lung Cancer Patients with Acquired Resistance to Tyrosine Kinase Inhibitors

By  

Oncology, Vol. 87, Iss. 2, 2014-07 ,pp. : 83-94

Karger

Access to resources Recommend Favorite

EGFR-Mutated Breast Metastasis of Lung Adenocarcinoma: A Case Report

By  

Case Reports in Oncology, Vol. 8, Iss. 1, 2015-03 ,pp. : 164-168

Karger

Access to resources Recommend Favorite

Phenotypic variation of an ALK‐positive large‐cell neuroendocrine lung carcinoma with carcinoid morphology during treatment with ALK inhibitors

By  

HISTOPATHOLOGY, Vol. 72, Iss. 4, 2018-03 ,pp. : 707-710

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rare oral metastasis from a probable large-cell neuroendocrine carcinoma of the lung

By Souron Béatrice   Weingertner Noëlle   Seigle-Murandi Frédéric   Goichot Bernard   Herbrecht Raoul   Schultz Philippe   Feki Ahmed   Hubele Fabrice   Bornert Fabien  

Médecine Buccale - Chirurgie Buccale, Vol. 22, Iss. 1, 2016-03 ,pp. : 49-54

Edp Sciences

Access to resources Recommend Favorite

RRx-001-Induced Tumor Necrosis and Immune Cell Infiltration in an EGFR Mutation-Positive NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors: A Case Report

By  

Case Reports in Oncology, Vol. 9, Iss. 1, 2016-01 ,pp. : 45-50

Karger

Access to resources Recommend Favorite